Recent advances in chemotherapy for cancer therapy over Cu-based nanocatalysts
Authors:
- 17 October 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (44) , 11336-11346
Abstract
Recently, the emerging chemotherapy (CDT) has provided a new biocompatibility pathway for cancer therapy. Among them, Cu-based nanocatalysts with good biocompatibility and Fenton-like catalytic efficiency are considered to be a promising approach for enhancing CDT and CDT-involved multimodal synergies to improve the effectiveness of catalytic cancer therapy. Meanwhile, the emerging in situ therapy strategy promoted by Cu-based nanocatalysts has proven to exhibit attractive clinical application potential in replacing traditional chemotherapy and radiotherapy for cancer therapy with significant toxic side effects. In this work, the recent progress of various Cu-based nanocatalysts in cancer therapy was reviewed, especially the remarkable achievements in the catalytic treatment of cancer in the tumor microenvironment using CDT and CDT-involved multimodal synergies. In addition, the development expectations and challenges of Cu-based nanocatalysts in the field of cancer therapy were briefly summarized and discussed. We expect that this review will contribute to the development of Cu-based nanocatalysts for cancer therapy.Keywords
This publication has 71 references indexed in Scilit:
- Bimetallic DNAsome Decorated with G4‐DNA as a Nanozyme for Targeted and Enhanced Chemo/Chemodynamic Cancer TherapyAdvanced Healthcare Materials, 2024
- Single‐Atom Cu Nanozyme‐Loaded Bone Scaffolds for Ferroptosis‐Synergized Mild Photothermal Therapy in Osteosarcoma TreatmentAdvanced Healthcare Materials, 2024
- Ultrathin 2D Pd/Cu Single‐Atom MOF Nanozyme to Synergistically Overcome Chemoresistance for Multienzyme Catalytic Cancer TherapyAdvanced Healthcare Materials, 2023
- A Novel Silver Nanoparticles‐Decorated Metal‐Organic Framework with Rapid and Sustained Antimicrobial Activity against Drug‐Resistant Candida albicans through Synergistic Chemodynamic and Sonodynamic TherapyAdvanced Therapeutics, 2023
- Atomically Dispersed Cu Nanozyme with Intensive Ascorbate Peroxidase Mimic Activity Capable of Alleviating ROS‐Mediated Oxidation DamageAdvanced Science, 2021
- Transitional Metal‐Based Noncatalytic Medicine for Tumor TherapyAdvanced Healthcare Materials, 2021
- Dual Size/Charge‐Switchable Nanocatalytic Medicine for Deep Tumor TherapyAdvanced Science, 2021
- Bioinspired Copper Single‐Atom Catalysts for Tumor Parallel Catalytic TherapyAdvanced Materials, 2020
- A Metal‐Organic Framework (MOF) Fenton Nanoagent‐Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy InhibitionAdvanced Materials, 2020
- Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like ReactionsAngewandte Chemie International Edition, 2018